Priority Date: 27.06.06 (US 20060816730P)

Human protein tyrosine phosphatase inhibitors and their use

  • Application ID: EP12196179
  • Status: The patent has been granted

Attorneys

no operation time available
1126.37
Headquarter in Cambridge and 3 offices
active in Legal Services
no operation time available
1126.37
Headquarter in Cambridge and 3 offices
active in Legal Services
Employment test 11 - 50 employees
Company dna hoefer and partner
operating since 1920
Headquarter in Munich, Bielefeld
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Avidity IP Ltd is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 27.06.2006 - Priority Date (US 20060816730P)
  • 15.05.2013 - Publication A2 (EP2592073)
  • 29.05.2013 - Publication A3 (EP2592073)
  • 30.08.2017 - Publication B1 (EP2592073)